Back to School: How biopharma can reboot drug development. Access exclusive analysis here

AVI-4658: Phase I/II started

AVII began a single-blind, placebo-controlled, dose-escalation, U.K.

Read the full 70 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE